Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bauer-Mehren

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2020
Prognostic models: clinical impact now within reachA Bauer-Mehren, D Rüttinger
Clinical Pharmacology and Therapeutics|April 11, 2013
Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting systemR Harpaz, W DuMouchel, P LePendu, et al.
Clinical Pharmacology and Therapeutics|June 13, 2013
Response to "Logistic regression in signal detection: another piece added to the puzzle"R Harpaz, W DuMouchel, P LePendu, et al.
Clinical Pharmacology and Therapeutics|April 11, 2013
Pharmacovigilance using clinical notesP LePendu, S V Iyer, A Bauer-Mehren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2020
An enhanced prognostic score for overall survival of patients with cancer derived from a large real-world cohortT Becker, J Weberpals, A M Jegg, et al.
European Journal of Epidemiology|February 16, 2010
Prediction of 60 day case-fatality after aneurysmal subarachnoid haemorrhage: results from the International Subarachnoid Aneurysm Trial (ISAT)R Risselada, H F Lingsma, A Bauer-Mehren, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2020
Prognostic models: clinical impact now within reachA Bauer-Mehren, D Rüttinger
Clinical Pharmacology and Therapeutics|April 11, 2013
Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting systemR Harpaz, W DuMouchel, P LePendu, et al.
Clinical Pharmacology and Therapeutics|June 13, 2013
Response to "Logistic regression in signal detection: another piece added to the puzzle"R Harpaz, W DuMouchel, P LePendu, et al.
Clinical Pharmacology and Therapeutics|April 11, 2013
Pharmacovigilance using clinical notesP LePendu, S V Iyer, A Bauer-Mehren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2020
An enhanced prognostic score for overall survival of patients with cancer derived from a large real-world cohortT Becker, J Weberpals, A M Jegg, et al.
European Journal of Epidemiology|February 16, 2010
Prediction of 60 day case-fatality after aneurysmal subarachnoid haemorrhage: results from the International Subarachnoid Aneurysm Trial (ISAT)R Risselada, H F Lingsma, A Bauer-Mehren, et al.
Pageof 1